Tobacco smoke affects not only people who smoke but also nonsmokers who are exposed to the environmental pollutants that are generated when tobacco products are burned. Sidestream smoke (SS), which is emitted from the tobacco products during puff intervals, constitutes the major source of such pollutants. Some of the mainstream smoke (MS) which escapes into the environment from the mouthpiece of the cigarette, cigar, or pipe after drawing a puff and that portion of the smoke exhaled by the smoker are further contributors to indoor air pollution. The exposure of nonsmokers to environmental tobacco smoke pollutants is also known as "passive smoking." 
Sidestream Smoke
The composition of SS differs significantly from that of MS. The SS generated between puff-drawing originates from a hydrogen-enriched, strongly reducing atmosphere. It contains, therefore, more combustion products than MS formed as a result of oxygen deficiency and thermal cracking. In addition, SS formation involves generation oflarger quantities ofreaction products of nitrates. Table 1 compares MS and SS from an 85-mm nonfilter cigarette (1) . These two tobacco combustion products are generated at distinctly different temperatures, and particle sizes in MS (0.1-1.O,um) are about 10 times those in SS (0.01-0.lium). This suggests that, upon inhalation, SS particles reach the more distant alveolar spaces of the lung to a greater extent than do the MS particles (2) . Above pH 6 , increasing amounts of unprotonated nicotine are present in the smoke. Therefore, SS (pH 6.4-6.6) contains more free nicotine in the gas phase than MS (3) .
About 300 to 400 of the more than 3800 individual compounds identified in tobacco smoke have been quantitatively determined in both MS and SS. Ratios >1.0 c At 10 mm distance from the burning coal.
in Table 2 (4) show that more of a given compound is released into SS than into MS. However, it must be realized that, in general, exposure to SS occurs after considerable air dilution, while the MS of cigarettes is inhaled without major dilution. The first part of Table 2 focuses on a comparison of a few volatile compounds in MS and SS. On the basis of the amount of tobacco burned during the smouldering of a cigarette without filter tip, SS to MS ratios should be between 1.3 to 1.7. This calculation is based on the assumption that the combustion processes during both phases of smoke generation are comparable. However, this is not the case, as indicated by the higher SS values for CO (2.5-4.7), CO2 (8) (9) (10) (11) , acrolein (8) (9) (10) (11) (12) (13) (14) (15) , and benzene (10) , and for the pyrolysis products of nicotine: pyridine (6.5-20) , 3-methylpyridine (3-13) , and 3-vinylpyridine . The lower SS value for hydrogen cyanide (0.1-0.25) also indicates that the generation of MS and SS is governed by different combustion processes. The higher SS yields of the reduction products of nitrate such as nitrogen oxide (4) (5) (6) (7) (8) (9) (10) , ammonia , methylamine (4.2-6.4), and especially the highly carcinogenic N-nitrosodimethylamine (20-100) and Nnitrosopyrrolidine (6-30) suggest higher toxicity and carcinogenicity for undiluted SS than for MS.
Similarly, compared to MS, the particulate phase of undiluted SS contains significantly higher amounts of carcinogenic amines (2-toluidine, 2-naphthylamine, 4 ,ug [8] [9] [10] [11] [12] [13] [14] [15] ,Lg [2] [3] [4] [5] ,ug 6.5-20 ,Lg [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] ,ug The most widely monitored indoor pollutant originating from tobacco is carbon monoxide. In controlled studies of enclosed spaces where machine-smoking occurred in the presence of people, CO levels ranged from 24 to 220 ppm without ventilation and were lowered to 4 to 80 ppm with 6 to 8.5 air exchanges per hour (5) . Table 3 lists reported values for toxic and carcinogenic tobacco smoke pollutants measured under natural conditions. In most cases, the reported pollution levels for Figure 1 demonstrates the association between cigarette smoking and the plasma levels of nicotine, cotinine, thiocyanate, and carboxyhemoglobin in whole blood. Nicotine and its metabolite, cotinine, are specific measures of tobacco consumption (9) , while levels of carboxyhemoglobin and thiocyanate can be influenced by a variety of environmental factors (10) . Cotinine, the major metabolite of nicotine, can be quantitated in plasma, saliva, and urine. Its assessment has proven helpful in differentiating smokers from nonsmokers aThe estimated exposure to the particulate phase of ambient tobacco smoke for U.S. adults of working age, at work and at home (these two microenvironments account for an estimated 88% of the average person's-both smokers' and nonsmokers'-time), determined from average concentrations of tobacco smoke calculated for model workplace and home microenvironments, weighted for average occupancy. Nonexclusive probability of being exposed at work, 63%; probability of not being exposed at work, 37%. Nonexclusive probability ofbeing exposed at home, 62%; probability ofnot being exposed at home, 38%. (22) (90) (43) (47) L. (24) (97) (47) even at low levels of daily cigarette use (11) . Changes in smoking behavior or compensation as smokers switch to low-yield cigarettes can be effectively monitored by measurements of plasma cotinine. Both nicotine and carboxyhemoglobin have short circulating half-lives such that measurement of these compounds limits their reliability to assess only very recent use of cigarettes (9) . Cotinine has a relatively long halflife, is specific to tobacco exposure, and can be measured at low levels in biological fluids. Currently, this measurement provides the best index of exposure to environmental tobacco smoke, as well as of active smoking behavior.
The uptake of nicotine and its metabolic conversion to cotinine in nonsmokers has been investigated under controlled conditions in exposure chambers (1, 12) and in free-living situations among adult (13, 14) and pediatric (15) populations.
To investigate uptake under controlled conditions, a laboratory was constructed to expose nonsmoking sub- (12) . The characteristics of this laboratory and pollution levels observed in it during the simultaneous smoking of four cigarettes are presented in Table 6 . Nonsmoking volunteers remained in the room for 80 mn, while saliva and blood samples were collected at 20-mn intervals during exposure and for 5 hr after leaving the chamber. Tables 7-9 show the analytical profiles of markers of tobacco smoke exposure in saliva, plasma, and urine. Thiocyanate and carboxyhemoglobin levels were not significantly elevated in volunteers following exposure. Nicotine was barely increased in plasma, but its metabolite, cotinine, was significantly elevated 2-3 hr after the start of the exposure. In saliva, nicotine levels rose rapidly to about 800 ng/mL. They quickly subsided after the volunteers left the room. When the volunteers were exposed to the pollutants of two, three, or four cigarettes, a doseresponse relationship for nicotine in s-aliva and cotini-ne in urine was observed. Further studies of this type confirmed the presence of cotinine in the urnme of nonsmokers.
In a study of patients attending an outpatient clinic, Jarvis et al. (13) found that the concentration of cotini-ne in body fluids was related to self-reported exposure to sidestream smoke. Salivary nicotine concentrations corresponded to the dose when exposure and testing occurred on the same day, but measures of thiocyanate and expired carbon monoxide were unrelated to the dose. A summary ofthe data byJarvis et al. is presented in Table 10 .
A similar study in Japan (14) examned exposures at home and in the workplace and revealed a dose-response relationship for cotini-ne excreted into the urine. The presence of smokers both in the home and at work elevated the cotinine levels with increased exposure time. An arbitrary designation of tobacco smoke density (not smoky, smoky, frequently smoky) as well as the number of smokers at a given site were related to increased cotinine to creatinine excretion ratio levels greater than those noted by researchers in the United States or in England (this discrepancy is believed to be methodo- 'Number of cigarettes bei-ng smoked throughout the exposure period.
'ND-= not detected-. logical in nature). This study did confirm, however, the utility of urinary cotinine to creatinine ratios in evaluating uptake of nicotine by nonsmokers. Wald et al. reported median urinary cotinine levels of 1645 ng/mL in cigarette smokers as compared to 6 ng/mL in nonsmokers exposed to environmental tobacco smoke and 2 ng/mL in those not exposed (16) . The cotinine levels in exposed nonsmokers increased substantially with the amount of exposure. The average measures represent a ratio of active to passive smoke exposure of 411, but this does not imply that cancer risk will necessarily be in the same ratio.
Greenberg et al. (17) measured the concentrations of nicotine and cotinine in the saliva and urine of infants with and without reported exposure in the household. The concentrations of both compounds were significantly higher in the exposed group than in the group without exposure. The best indicator of chronic exposure was the urinary cotinine to creatinine ratio, with a direct relationship between cotinine excretion by the infants and the self-reported smoking behavior of mothers during the previous 24 hr (Fig. 2) .
The results of chamber studies as well as free-living evaluations of nonsmokers exposed to sidestream smoke suggest that measurement of urinary cotinine excretion can provide a reliable, objective indicator of exposure to sidestream smoke.
In summary, there is no question that individuals are exposed to environmental tobacco smoke. Although such exposure may be relatively low compared to active cigarette smoking, uptake of environmental tobacco smoke pollutants begins very early in life and is directly related to the degree of exposure. The degree of exposure is a function of the number of persons contributing to smoke pollution, the amount oftobacco products being smoked, and the dimensions and ventilation characteristics of the rooms and buildings in which exposure occurs, as well as the duration of exposure.
Risk of Lung Cancer
The relationship of the risk of lung cancer to environmental tobacco smoke has been studied in classic case-control and longitudinal studies. Most of the studies have measured the risk of lung cancer or the odds ratio among nonsmoking lung cancer cases, usually women, in relationship to the smoking habits of the spouse, parents, or co-workers. Only a few studies have included men or smokers as index cases. It is important to note that most lung cancer cases in men occur in current or former cigarette smokers and that a high percentage of lung cancers occurring among nonsmokers, especially women, are predominantly adenocarcinoma rather than epidermoid carcinoma. The estimated incidence of lung cancer among both men and women who were lifetime nonsmokers was only about 10 per 100,000.
In the large series in the Mayo Clinic, only 70 cases (3%) of lung cancer in men occurred among nonsmokers, and apparently 55% of the 70 cases were adenocarcinoma (Table 11) . Among women, 148 of 515 cases (29%) occurred among nonsmokers, and 68% were adenocarcinoma (18 Tables 13 and  14 . These studies include cohort studies and a number of case-control studies that compare nonsmoking women with lung cancer to nonsmoking women with other diseases. These studies seem to indicate that passive smoke exposure plays a role in causing cancer in nonsmoking women. However, individually, each of these studies-positive or negative-suffers methodologic weaknesses. The problems of greatest concern are the possibility of misclassification of both active and passive smoking status, misclassification of tumor pathology, use of inappropriate controls, and small sample sizes.
Misclassification of Exposure
Misclassification of exposure has been an overwhelming concern of the critics of the published studies. This has been especially true for the studies done in Japan (22) (23) (24) and Greece (25) , where surprising numbers of cancers were seen in nonsmokers. The possibility of "closet smoking" by these nonsmoking women married to smokers has been suggested but has never been confirmed. However, ifit is true that few Japanese or Greek women smoke, it is not surprising that few of the women with lung cancer are smokers. This does not indicate a problem with these studies unless there are more cancers than could be expected in a nonsmoking population. Misclassification is perhaps of greater concern in some of the other studies where the reported relative risks and sample sizes have been smaller (20, (26) (27) (28) (29) and therefore more likely to change with a small amount of misclassification.
Recall bias in reporting passive smoke exposure is also a major potential problem in the case-control studies. Childhood smoke exposure histories were validated in the North Carolina study, and there did not appear to have been differential recall (30) . Similar data are not available for smoking by a spouse. In the cohort studies, changes in exposure status over time rather than differential misclassification of passive smoke exposure is of concern. Other studies, such as that in Hong Kong (26) , have obtained information only on current cigarette smoke exposure, and thus persons with past exposures may be misclassified. (25) . This is a much larger proportion of nonsmokers among epidermoid cancer patients than would be expected from U.S. data. One possible explanation is that women in the Trichopoulos et al. study were in fact smokers. Alternatively, because pathologic confirmation was not always available and available data were not systematically reviewed, these cases may be misclassified according to lung pathology. In fact, none of the studies included independent review of pathology, and classification may be affected by individual variations in interpretation and changes over time in standards. An exception is the study of Garfinkel et al. in which the histology of both cases and controls was reviewed (31) .
Misclassification of Pathology

Sample Size
In many of the studies, there are too few nonsmoking lung cancer cases to produce reliable estimates of the relative risk. For example, some American studies have involved 22 lung cancers, of which only two were in nonsmokers (30, 32) ; 35 lung cancers in nonsmokers (20) ; and 29 nonsmoking cases in another study (27) .
A new American study in four hospitals over an 11-yr (31) . One report suggested that colorectal cancer risk may be decreased among smokers (37) , although this has not been found in many other studies. The multicenter U.S. study used all other cancers for comparison, some of which may be related to both active and passive smoking (19, 38) and may, therefore, underestimate risk from passive smoke exposure. This may be more true for .aA females than for males, where sites such as the cervix have been increasingly linked with both active and passive smoke exposure.
Other Cancers and Chronic Diseases
Several other studies have examined total mortality, cardiovascular disease, and cancers of nonrespiratory sites. These studies are generally preliminary in nature. Garland et al. reported an excess of ischemic heart disease deaths among nonsmoking women exposed to tobacco smoke, but the study was quite small, and the risks were unstable (39) . Preliminary results of the follow-up of never-smoking or nonsmoking men in the Multiple Risk Factor Intervention Trial have shown excesses of both total and coronary heart mortality among men whose wives smoked, as compared to those whose wives did not smoke (40) . Other studies (24, 33) also offer some support for a possible effect of passive smoking on heart disease risk. Vandenbroucke et al. reported on total mortality in relation to passive smoke exposure, but the study was too small to identify any real effects (41) . Furthermore, women married to ex-smokers were considered nonexposed, which may have limited the likelihood of observing any effects. In a study to evaluate cancer risk from childhood exposures, which also included data on spouse smoking, a significant association with nonrespiratory sites was observed (32) . However, the study was not able to control for many known risk factors or potential confounding factors for cancers of specific sites. Hirayama (23) has also observed associations between spouse's smoking and nonrespiratory tract cancers but did not obtain data on many potential confounding variables.
Childhood Exposures
Cigarette smoke exposure also occurs in early life, and mothers' or fathers' smoking may be associated with increased cancer risk in childhood or even adulthood. Data from recent biochemical studies indicate that children of mothers and fathers who smoke are meaningfully exposed in utero and in childhood to the potential carcinogens in cigarette smoke (15, 34, 37, (39) (40) (41) (42) (43) (44) (45) (46) (47) . Studies in animals of effects of exposure to particular chemicals, including some that are in cigarette smoke, suggest that these chemicals may be transplacental carcinogens for humans and that effects of transplacental or early life exposures may be greater than effects from similar levels of exposure later in life (48) (49) (50) (51) . Furthermore, animal studies also suggest that resulting tumors may include multiple sites and may be of adult morphology (49) .
In a large retrospective study of childhood cancers, Stewart et al. (52) observed a small but significant relative risk associated with mother's cigarette smoking during pregnancy. In a smaller prospective study, Neutel and Buck (53) reported a 30% increase in risk of childhood cancer associated with mothers' smoking that was not quite statistically significant. Case-control studies of individual childhood tumors have also reported positive associations with parents' smoking (54-56), although other studies do not report such effects. These studies are summarized in Table 15 .
Studies in animals also suggest that some effects from early life exposures may not be apparent until adult life (47) . If true, this suggests that some studies of parents' smoking and childhood cancers might be negative because an effect might not be apparent until adulthood. Epidemiologic studies in humans have recently sug- (73) C/C Testis to 40 1.0 mothers Gold (56) C/C Brain to 20 5.0 smoking mothers who continued in pregnancy Manning (74) C/C Leukemia to 15 1.0 mothers Stewart (52) C/C All to 10 1.1 mothers Neutel (53) cohort All to 10 1.3 mothers during pregnancy
Grufferman (55) C/C Rhabdomyoto 15 3.9 fathers sarcoma during pregnancy 1.0 mothers in pregnancy a C/C = case-control study.
gested the possibility of an association between transplacental or early life exposure to cigarette smoke and adult cancers, including cancers of the respiratory tract and other nonrespiratory sites, although these studies must be considered preliminary (20, 27, 32) (Table 16 ).
Conclusions
The relationship of environmental tobacco smoke and disease, specifically lung cancer and possibly other respiratory tract cancer, is important. First, there are obvious public health implications, given that perhaps 60% of the population is exposed to environmental tobacco smoke. Second, confounding of environmental tobacco smoke exposure with other environmental and occupational risks is possible. Third, information learned about passive smoking may help increase our understanding of the relationship between long-term exposures to relatively low dose carcinogens and subsequent disease.
A greater number of lung cancers in nonsmokers are found in women, and studies to date, although not conclusive, indicate that environmental tobacco smoke is probably related to lung cancer in women. It is unlikely (27) C/C Lung 1.7 mother, adenocarcinoma 1.3 father, adenocarcinoma 0.2 mother, squamous cell 0.9 father, squamous cell a C/C = case-control study.
that a significant effect of environmental tobacco smoke and active cigarette smoking synergistically can be identified from most of these epidemiologic studies.
Exposures very early in life to environmental tobacco smoke may be important in relationship to the subsequent development of cancer and need to be considered. Only a few studies to date have evaluated the relationship between environmental tobacco smoke and subsequent childhood cancers, and almost none have evaluated cancers that occur in adulthood. The short-term effects of environmental tobacco smoke on the cardiovascular system, especially among high-risk individuals, may be of even greater concern than that of cancer.
Further study of the increased risks of lung cancer in relation to environmental tobacco smoke exposure will require larger collaborative studies to identify more lung cancer cases among noncigarette smokers, better delineation of pathology, and more careful selection of controls.
Finally, it may be possible to consider studies of epithelial cells or specific cytology to determine at least evidence of cellular changes in relationship to environmental tobacco smoke exposure. Environmental tobacco smoke exposure is most likely the most important indoor air pollutant.
Research Recommendations Epidemiologic Studies
Recommendation 1: There should be continued efforts to measure individual exposures to passive smoking. At present, measurement of urinary cotinine appears to be the best method. Other chemicals should be evaluated as well as specific biological markers. Personal direct monitoring should have high priority.
Recommendation 2: Additional case-control studies are needed to evaluate the relationship between passive smoking and lung cancer. Such studies should include primary noncigarette smokers with lung cancer patients as cases and appropriate controls. It is important that these studies include a broad age range; specific pathological type of lung cancer; and careful records of the history of cigarette smoking in parents, spouses, at-work environment, other possible risk factors, occupation, and environmental exposure.
Recommendation 3: Case-control studies should be done to investigate the possible association between passive smoke exposure in childhood and adulthood and risk for cancer of other sites. Such studies should include attention to other known risk factors for cancer at these sites and include data on relevant confounding factors.
Differences between sidestream smoke and mainstream smoke-such as the higher levels of specific carcinogens in fixed volumes of sidestream smoke versus mainstream smoke, smaller particle size, and the possible different deposition in the lung-suggest that passive smoke exposure may not be just a lower dose of active smoke exposure. Passive smoking results in pos-sible systemic exposures. Preliminary studies have reported associations between passive smoke exposure and nonrespiratory tract sites.
Studies of the health effects of cigarette smoke exposure should attempt to identify a truly nonexposed comparison group. While active smokers are also passive smokers, health effects that are specific to sidestream smoke cannot be identified in studies of smokers versus nonsmokers where nonsmokers also include passive smokers.
Recommendation 4: Childhood cancers and susceptibility to adult cancers should be evaluated in light of early life exposure to passive smoking or to mainstream smoke in utero. Childhood exposure to passive smoking can begin in utero, where the fetus is exposed to the mainstream smoke inhaled by the mother. Exposure can continue through infancy and childhood as sidestream smoke generated by the parents, caretakers, or associated adults is absorbed by the child. The absorption of nicotine by infants has been shown to be dose responsive and can result in high levels ofurinary cotinine.
Recommendation 5: If possible, a cohort longitudinal study of passive smoking and lung cancer should be done. The sample size would require about 100,000 middle-aged women with an average cancer risk of 10 per 100,000 per year, followed for up to 10 years. Such large cohorts already exist (NCI breast cancer screening studies, NHLBI cohorts, etc.). In any such study, an attempt should be made in all these studies to build in some measure of passive smoking, such as urinary cotinine, as well as history of exposure. The cotinine could be measured in a nested case-control study.
Recommendation 6: A specific case-control study of well-documented adenocarcinoma of the lung should be done. Variables to be studied should include active smoking, passive smoking, environmental exposures, family history, diet (i.e., vitamin A, carotene), alcohol intake, and other cancers in the case, as well as the family. Validation of the pathological diagnosis is critical in such studies.
Recommendation 7: The distribution of exposure to passive smoking in different population groups should be described by various sampling strategies using existing population study sources and measurement of passive smoking by urinary cotinine and other suitable markers.
Recommendation 8: If possible, the type of study of bronchial epithelial changes in postmortem specimens should be done for noncigarette smokers with attention to passive smoking exposures.
Experimental Studies
Recommendation 9: If possible, the relationship between sidestream smoke exposure or mainstream smoke exposure with lung cancer should be evaluated in animal models. Experimental studies could be particularly useful in elucidating such issues as the relative risks of transplacental versus childhood exposures and their importance to the development of lung cancer.
Recommendation 10: Long-term animal inhalation studies with passive smoke are needed. It is recommended that such studies be done in two anlimal species, preferably rats and Syrian golden hamsters. Emphasis should be placed on the induction of tumors in the respiratory tract and other organs. Early histopathological changes in the respiratory tract should be investigated in these assays.
Recommendation 11: Animal inhalation studies with passive smoke should also be initiated with respect to transplacental carcinogenesis. Detailed biochemical research is required.
Recommendation 12: In-depth studies are needed to clearly delineate the differences in the physical natures and chemical compositions of sidestream and mainstream smoke. It has been established that the physiochemical nature of passive smoke, the smoke inhaled by nonsmokers, differs significantly from the mainstream smoke inhaled by the active smoker. Data are needed to delineate these differences.
